201 related articles for article (PubMed ID: 1649252)
61. Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Battaglia G; Busceti CL; Molinaro G; Biagioni F; Traficante A; Nicoletti F; Bruno V
J Neurosci; 2006 Jul; 26(27):7222-9. PubMed ID: 16822979
[TBL] [Abstract][Full Text] [Related]
62. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
Giovanni A; Sonsalla PK; Heikkila RE
J Pharmacol Exp Ther; 1994 Sep; 270(3):1008-14. PubMed ID: 7932148
[TBL] [Abstract][Full Text] [Related]
63. Effect of manganese exposure on MPTP neurotoxicities.
Baek SY; Lee MJ; Jung HS; Kim HJ; Lee CR; Yoo C; Lee JH; Lee H; Yoon CS; Kim YH; Park J; Kim JW; Jeon BS; Kim Y
Neurotoxicology; 2003 Aug; 24(4-5):657-65. PubMed ID: 12900079
[TBL] [Abstract][Full Text] [Related]
64. Contrasting tissue factors predict heterogeneous striatal dopamine neurotoxicity after MPTP or methamphetamine treatment.
Marshall JF; Navarrete RJ
Brain Res; 1990 Nov; 534(1-2):348-51. PubMed ID: 2073599
[TBL] [Abstract][Full Text] [Related]
65. Role of heat shock proteins in MPTP-induced neurotoxicity.
Freyaldenhoven TE; Ali SF
Ann N Y Acad Sci; 1997 Oct; 825():167-78. PubMed ID: 9369985
[TBL] [Abstract][Full Text] [Related]
66. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
67. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
Lee EH
Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360
[TBL] [Abstract][Full Text] [Related]
68. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
Melamed E; Rosenthal J; Cohen O; Globus M; Uzzan A
Eur J Pharmacol; 1985 Oct; 116(1-2):179-81. PubMed ID: 3876943
[TBL] [Abstract][Full Text] [Related]
69. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
[TBL] [Abstract][Full Text] [Related]
70. The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
Miller DB; Ali SF; O'Callaghan JP; Laws SC
Ann N Y Acad Sci; 1998 May; 844():153-65. PubMed ID: 9668673
[TBL] [Abstract][Full Text] [Related]
71. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Melamed E; Rosenthal J; Youdim MB
J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
[TBL] [Abstract][Full Text] [Related]
72. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
Jonsson G; Nwanze E; Luthman J; Sundström E
Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
[TBL] [Abstract][Full Text] [Related]
73. EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.
Rojas P; Rojas C; Ebadi M; Montes S; Monroy-Noyola A; Serrano-García N
Neurochem Res; 2004 Jul; 29(7):1417-23. PubMed ID: 15202774
[TBL] [Abstract][Full Text] [Related]
74. Role of CYP2E1 in the mouse model of MPTP toxicity.
Pardini C; Vaglini F; Viaggi C; Caramelli A; Corsini GU
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S119-23. PubMed ID: 18583171
[TBL] [Abstract][Full Text] [Related]
75. Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain stem of the rat.
Desole MS; Miele M; Esposito G; Fresu LG; Migheli R; Zangani D; Sircana S; Grella G; Miele E
Pharmacol Biochem Behav; 1995 Aug; 51(4):581-92. PubMed ID: 7675829
[TBL] [Abstract][Full Text] [Related]
76. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444
[TBL] [Abstract][Full Text] [Related]
77. Effect of sex and gonadectomy on brain MPTP toxicity and response to dutasteride treatment in mice.
Isenbrandt A; Morissette M; Bourque M; Lamontagne-Proulx J; Coulombe K; Soulet D; Di Paolo T
Neuropharmacology; 2021 Dec; 201():108784. PubMed ID: 34555366
[TBL] [Abstract][Full Text] [Related]
78. Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity.
Rojas P; Franco-Pérez JE; Rojas C; Rojas-Castañeda J; Ebadi M; Fernández-Valverde F; Serrano-García N
Neurotoxicology; 2005 Dec; 26(6):959-68. PubMed ID: 15950287
[TBL] [Abstract][Full Text] [Related]
79. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
80. Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice.
Takahata K; Shimazu S; Yoneda F; Ogawa M; Iida Y; Saji H
J Neural Transm (Vienna); 2003 Aug; 110(8):859-69. PubMed ID: 12898342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
